Free Trial

Asset Dedication LLC Has $933,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Asset Dedication LLC cut its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 31.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,263 shares of the company's stock after selling 4,807 shares during the quarter. Asset Dedication LLC's holdings in Colgate-Palmolive were worth $933,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. State Street Corp raised its holdings in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Geode Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock worth $2,095,325,000 after acquiring an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock worth $988,997,000 after acquiring an additional 557,492 shares during the period. Barclays PLC raised its holdings in shares of Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after acquiring an additional 2,132,747 shares during the period. Finally, FMR LLC raised its holdings in shares of Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after acquiring an additional 2,674,807 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CL. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating on the stock in a report on Friday, January 17th. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. UBS Group decreased their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating for the company in a research report on Thursday, January 16th. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a research report on Thursday, January 16th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $102.00.

Read Our Latest Research Report on CL

Colgate-Palmolive Stock Performance

Shares of CL stock traded up $1.39 during midday trading on Thursday, hitting $90.96. 5,414,345 shares of the company were exchanged, compared to its average volume of 5,071,273. The firm has a market capitalization of $74.31 billion, a P/E ratio of 26.06, a PEG ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The firm's 50 day moving average price is $91.58 and its two-hundred day moving average price is $97.29. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's payout ratio is 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.34% of the company's stock.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines